Our NUHS Medical Oncology Senior Residency Programme at the National University Cancer Institute, Singapore (NCIS) is committed to training well-rounded oncologists who are competent, compassionate and capable of making substantial contribution to patient care, education and research.
The three-year programme is designed to meet all educational requirements expected of an ACGME-I approved programme and to prepare its graduates for certification by the Singapore Specialist Accreditation Board (SAB) in Medical Oncology. The first 24 months fulfill the requirements of the ACGME-I and the last 12 months fulfill the SAB requirements for specialist certification in medical oncology in Singapore.
In the first two clinical years, senior residents will be rotated through various rotations involving different tumour types, the length of each clinical rotation ranging from two to four months. Each rotation will be devoted to one to two main disease sites with close supervision from faculty. Senior residents will be required to attend diligently the multi-disciplinary tumour boards for that particular rotation.
A unique feature of the programme is the autonomy and flexibility afforded to our senior residents to organise and schedule their own continuity clinic patients. Throughout their training, senior residents accumulate patients to their continuity clinic panel, and are looked upon as the patient’s primary oncologic physician, with significant clinical decision responsibilities. This ensures that by the end of senior residency, they are extremely well prepared for clinical practice.
In addition to inpatient and outpatient clinical rotations, senior residents rotate through other departments such as Radiation Oncology, Malignant Haematology, and Palliative Care ensuring comprehensive training. Educational sessions for senior residents include a twice-weekly core lecture series, journal clubs, board review sessions, medical grand rounds, and annual in-training examinations in Medical Oncology to prepare senior residents for the exit exams.
The NCIS through its research arm, Haematology-Oncology Research Group (HORG) and collaborative efforts with the Cancer Science Institute, Singapore (CSI) at the National University of Singapore (NUS) provides a rich menu of research opportunities for senior residents to pursue during their dedicated research. Multiple programmes in respective solid tumor groups, pharmacogenetics, drug development, and supportive care, provide senior residents with opportunities for either basic science, translational and clinical research. There are over 200 clinical trials at the NCIS and senior residents are involved in writing and development of clinical trials. Past and current senior residents have been very successful in publishing their research in peer-reviewed journals and presenting abstracts and oral presentations at national and international conferences.
For more information on the NUHS Medical Oncology Senior Residency Programme, please download the brochure below -
Dr Yvonne Ang Li'en
Programme Director, Medical Oncology Senior Residency Programme, NUHS
Dr Matilda Lee
Associate Programme Director,
Medical Oncology Senior Residency Programme, NUHS
Dr Chong Wan Qin
Core Faculty,
Medical Oncology Senior Residency Programme, NUHS
Dr Alvin Wong
Core Faculty,
Medical Oncology Senior Residency Programme, NUHS
"The NUHS Medical Oncology Senior Residency Programme provides an environment of rigorous clinical training.
The faculty is deeply involved in furthering resident knowledge of the field while also being enjoyable to work with. There were ample research opportunities and I was able to actively participate in clinical trials.
The NUHS training programme helped me develop into a more holistic Oncologist."
Programme Director
Dr Yvonne Ang Li'en
[email protected]
Programme Coordinator
Ms Ann Koh
[email protected]